comparemela.com

Company Or Freeline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |Syncona Limited Announcements | Syncona Limited: Freeline reports Q1 2022 Financial Results

Investegate announcements from Syncona Limited, Freeline reports Q1 2022 Financial Results

United kingdomUnited statesCity ofPaul schneiderMichael pariniArne naevekeHenning stennickeCollins fergus wittCompany or freelineFreeline therapeutics plcExchange commissionCompany annual report on formDevelopment rd expensesKey clinical program updatesSyncona ltdUnited kingdom or european union

Freeline To Present at the 25th Annual Meeting of the American Society of Gene and Cell Therapy

LONDON, May 02, 2022 Freeline Therapeutics Holdings plc today announced the upcoming presentation of five posters at the 25th Annual Meeting of the American Society of Gene and Cell. | May 2, 2022

United statesUnited kingdomCity ofArne naevekeExchange commissionCompany or freelineCompany annual report on formHead of corporate communicationsFreeline therapeutics holdingsMeeting of the american society geneTherapeutics holdingsAnnual meetingAmerican societyCell therapyAnnual reportStatement regarding forward looking

Freeline Announces Updated Development Plan and Timelines for FLT190 for People with Fabry Disease

Company to progress to second dose cohort in the MARVEL-1 study immediately, with first patient dosing expected in mid-2022 LONDON, March 24, 2022 Freeline Therapeutics Holdings plc . | March 24, 2022

United statesUnited kingdomCity ofMichael pariniArne naevekePamela fouldsCompany or freelineCompany phaseData monitoring committeeCompany annual report on formHead of corporate communicationsGlobenewswire incFreeline therapeutics holdingsTherapeutics holdingsChief medical officerChief executive officer

Freeline Announces $26 1 Million Registered Direct Offering of American Depositary Shares

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesUnited kingdomCity ofArne naevekeCompany or freelineWedbush securities incFreeline therapeutics incFinancial servicesExchange commissionCompany annual report on formEuropean union withdrawalSyncona portfolioHead of corporate communicationsFreeline therapeutics holdingsTherapeutics holdings

Freeline Announces First Patient Dosed in the Phase 1/2 B-LIEVE Dose-Confirmation Trial in Hemophilia B

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomCity ofMichael pariniArne naevekePamela fouldsExchange commissionCompany annual report on formCompany or freelineCompany phaseHead of corporate communicationsFreeline therapeutics holdingsTherapeutics holdingsChief medical officerChief executive officerAnnual report

vimarsana © 2020. All Rights Reserved.